Anchyra Partners
AMGN icon

Anchyra Partners’s Amgen AMGN Stock Holding History

Anchyra Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.41M Buy
3,345
+251
+8% +$100K 0.3% 62
2026
Q2 		$1.12M Buy
3,094
+104
+3% +$35.6K 0.27% 73
2026
Q1 		$1.05M Buy
2,990
+131
+5% +$46.7K 0.32% 67
2025
Q4 		$936K Buy
+2,859
New +$907K 0.29% 73

Other funds holding AMGN

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Anchyra Partners's AMGN Position: Q3 2026 in Review

Anchyra Partners increased its Amgen (AMGN) stake by 8.1% in Q3 2026, buying an estimated $100K and bringing the position to 3,345 shares worth $1.41M. The position accounts for 0.3% of the portfolio, ranked #62.

Anchyra Partners first reported a position in AMGN in Q4 2025 and has held it in 4 quarters since. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Anchyra Partners held 3,345 shares of Amgen worth $1.41M as of Q3 2026.
  • Anchyra Partners bought 251 Amgen shares in Q3 2026, an estimated $100K.
  • Amgen made up 0.3% of Anchyra Partners's portfolio in Q3 2026, its #62 holding.
  • Anchyra Partners first reported a position in Amgen in Q4 2025 and has held it in 4 quarters since.
  • 2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Anchyra Partners's 13F filing for Q3 2026, filed 13 Oct 2026.